- Oral presentation
- Open Access
New polyurethane prostheses for substitution of cardiac valve disease and remodeling of the right ventricle in congenital heart malformations
© Maluf; licensee BioMed Central Ltd. 2013
- Published: 11 September 2013
- Congenital Heart Disease
- Congenital Heart
- Compute Tomography Angiography
- Aortic Annulus
- Prosthetic Heart Valve
The biological cardiac prosthesis on the market today, are durable and functional, but still not the ideal valve replacement in children.
Develop three different models of polyurethane prostheses prototypes for substitution in cardiac valve disease and remodeling of the right ventricle, in patients with congenital heart disease.
Based on a computed tomography angiography of the aorta, we made a delrin ring, keeping the anatomical characteristics of the aortic annulus. A matrix one following we made from stainless steel with the shape of the three cusp aortic valve, followed by preparation of the injection of liquid polyurethane segmented (SPU), using a esterolitografia technique. In vitro tests: The materials used in the manufacture of prostheses were approved in biocompatibility testing according to ISO 10993 - Biological evaluation of medical devices. The dentures will undergo physical tests, hydrodynamic and durability according to ISO 5840 - Cardiovascular Implants - Prosthetic heart valves.
The macroscopic appearance of these prototypes was approved by the group of Engineer, Biologist and Pediatric Cardiac Surgeon. It will be observed the macroscopic and microscopic optical and electronic scanning and imaging studies. The data will be sorted by making emphasis on the degree of calcification, presence of thrombi, infection and integrity of the prosthesis SPU. Experimental studies published showed good hemodynamic performance of the polyurethane prostheses, implanted on the right side of the heart: the absence of significant pressure gradients.
It is possible to reproduce these results and further studies, carried out to better understand the properties of the SPU and level of reliability with a view on release, compared to health authorities for clinical application, thus becoming one more option among the prostheses on the market today.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.